Dennis N. Berman

Executive VP, Corporate Dev, KINTERA INC.

Companies

Inhibikase Therapeutics, Inc.Board member Dec 22, 2020 to now¹
Forte Biosciences, Inc.Board member Apr 12, 2017 to Apr 12, 2017²
Forte Biosciences, Inc.EVP, Corp Development Apr 12, 2017 to Apr 12, 2017²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Inhibikase Therapeutics, Inc. IKT21,854 shares³$40.0K at $1.83Jul 30, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 30, 2026Exercised options 21,854 shares at $1.26 of Inhibikase Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARInhibikase Therapeutics, Inc., Board member
2
SEC EDGARForte Biosciences, Inc., Board member
3
SEC EDGARInhibikase Therapeutics, Inc. shares after the filing of Jul 30, 2026